about
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonistsAtrial Fibrillation And Coronary Heart Disease:Fatal Attraction.Comparison of the clinical features and outcomes in two age-groups of elderly patients with atrial fibrillation.Prevention strategies for cardioembolic stroke: present and future perspectives.Could some geriatric characteristics hinder the prescription of anticoagulants in atrial fibrillation in the elderly?Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trialEarly experience using a left atrial appendage occlusion device in patients with atrial fibrillationPreventing stroke in atrial fibrillation patients - clinical utility of oral anticoagulants.Individual and Combined Risk Factors for Incident Atrial Fibrillation and Incident Stroke: An Analysis of 3 Million At-Risk US Patients.Current genomics in cardiovascular medicineAdherence to treatment guidelines: the association between stroke risk stratified comparing CHADS2 and CHA2DS2-VASc score levels and warfarin prescription for adult patients with atrial fibrillationStroke in Atrial Fibrillation - Long-term Follow-up of Cardiovascular Events.Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000-2009Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation.Cost-effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients.Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.Von Willebrand Factor Plasma Levels Variability In Nonvalvular Atrial Fibrillation.Catheter Ablation of Atrial Fibrillation in Females.Stroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation.Preventative Measures of Stroke in Patients With Atrial Fibrillation.AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score.Warfarin-amiodarone drug-drug interactions: determination of [I](u)/K(I,u) for amiodarone and its plasma metabolites.Improving anticoagulation in atrial fibrillation: observational study in three primary care trusts.Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC).Stroke prevention in atrial fibrillation patients.Peri-operative management of ophthalmic patients taking antithrombotic therapy.Future epidemic impact of atrial fibrillation and a new interventional strategy for stroke prophylaxis.Atrial fibrillation and vascular disease--a bad combination.The emergence of factor Xa inhibitors for the treatment of cardiovascular diseases: a patent review.Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease.Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation.The prevalence, impact and economic implications of atrial fibrillation in stroke: what progress has been made?Protecting the brain and the heart: antithrombotic treatment in nonvalvular atrial fibrillation.Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey.Management of acute poststroke blood pressure and detection of atrial fibrillation: a postal questionnaire of UK stroke physicians' current clinical practice.Impact of gout on the risk of atrial fibrillation.Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk.Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study.Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.Mitral isthmus ablation using a circular mapping catheter positioned in the left atrial appendage as a reference for conduction block.
P2860
Q24647947-2A43D8A6-E525-4451-97B9-48DB582DECBFQ33574018-0FFB2B96-22E8-4287-81A9-6937F872834FQ34062233-73E1CED6-ABF5-4AA2-A1F9-F861CEBB7DECQ34072190-B32F599D-E5BC-4F66-AE5D-32352C37C486Q34245296-32141DDC-1605-43BF-8A47-CA182CD4807FQ35062723-76C0666A-D562-4A60-A308-F2D755087A0EQ35648223-EB5AF69A-B92F-45D9-B70B-7E1BF20922EDQ35938914-8CD6B297-88DB-4633-B7A3-432E9DC24FD2Q36168690-E4E4F96A-A690-4B0A-82EE-B114F164A435Q36186424-16ECF78E-2242-4426-AE2D-543D38E8B7A4Q36277366-3C51C03C-284A-435B-8376-26E2A5943495Q36458873-8CBC3904-5FBE-4921-A028-0FA4291832E5Q36550795-94AB6C8B-06CD-4B7E-9CCD-BC23B7C5A63DQ37073803-FF378256-7833-4B3C-ABD7-4172E3E0A5F8Q37184310-EF32165D-3FEB-4FA6-8F24-51E4AC7CB27BQ37246263-244BC03D-4ED9-4678-B204-9DBF8546CBEDQ37468947-48F74060-D30D-43A1-8133-1A8895BB6484Q37495821-89A58505-10DA-4916-92C2-2865BCE3EB6DQ37495877-FE6AF22A-3A71-4930-8D3A-31068E1EF52EQ37496186-256BF4D8-8E67-4F4F-BBFE-E50CC906B1AEQ37496271-214550DC-8B06-4DAE-AA14-3FBC8A61D5E3Q37509103-3B239219-D4DB-4D1E-AB49-61412D4B97ADQ37725772-FA0C1FA4-6BDA-40E4-A3F9-D01B63CEDE5CQ37779432-EC904205-E5A0-4D6F-A212-E53262D75AF9Q37780750-1349BFC4-D662-4A02-9020-F707D6D2EFF6Q37840280-94B277BD-CD23-4F80-A275-9670138E2A49Q37859753-F73631E4-E66E-4E06-919F-2D741090DBD7Q37975985-46C9903B-B38A-4A38-85D8-45DA39090A3DQ38015427-1390BDEF-0716-458F-B9E8-1BE5C85341B1Q38065252-4B387544-4586-48C3-8620-AECC6AA25C0EQ38074906-1CD4FC1A-6D2B-4B05-81AA-64EB2AFB41BBQ38077894-45B8587E-711C-4473-A780-97DCB4D57610Q38101903-C04273F3-AB1D-4EB1-B933-C41D36A4D911Q38106663-68885F4F-48E6-4F9D-AC6B-6E93880BF6F6Q39544096-DEEACDBF-0DCD-4CF0-803B-7712E7E61344Q40195623-D2877CAF-5398-4A3B-878A-ECB4EA4ADFDAQ40285966-53918D00-E188-4780-8F18-5B4DF43F9747Q40704670-7E249B3F-15CB-4326-B23B-1A2D21A951CBQ41527939-F1D964A7-74B8-4BF7-8403-81FEE6A1E468Q41592872-5F5984B6-0613-4623-A82C-529E0FA6AEB0
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Atrial fibrillation and stroke prevention
@ast
Atrial fibrillation and stroke prevention
@en
Atrial fibrillation and stroke prevention
@nl
type
label
Atrial fibrillation and stroke prevention
@ast
Atrial fibrillation and stroke prevention
@en
Atrial fibrillation and stroke prevention
@nl
prefLabel
Atrial fibrillation and stroke prevention
@ast
Atrial fibrillation and stroke prevention
@en
Atrial fibrillation and stroke prevention
@nl
P3181
P1433
P1476
Atrial fibrillation and stroke prevention
@en
P2093
Hoong Sern Lim
P304
P3181
P356
10.1016/S1474-4422(07)70264-8
P407
P577
2007-11-01T00:00:00Z